374 filings
Page 7 of 19
6-K
BNTX
BioNTech SE
20 Apr 22
Invitation to the Annual General Meeting 2022
6:24pm
D
BNTX
BioNTech SE
14 Apr 22
$150M in equity, sold $150M, 1 investor
11:11am
6-K
BNTX
BioNTech SE
14 Apr 22
Current report (foreign)
8:57am
6-K
BNTX
BioNTech SE
11 Apr 22
BioNTech Presents Positive Preliminary Phase 1/2 Data
8:24am
6-K
BNTX
BioNTech SE
11 Apr 22
BioNTech Granted Pandemic Preparedness Contract by German Federal Ministry of Health
8:11am
6-K
BNTX
BioNTech SE
31 Mar 22
BioNTech Announces ADS Repurchase Program
7:09am
20-F
2021 FY
BNTX
BioNTech SE
Annual report (foreign)
30 Mar 22
8:15am
6-K
BNTX
BioNTech SE
30 Mar 22
BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
7:24am
6-K
BNTX
BioNTech SE
29 Mar 22
Current report (foreign)
4:40pm
6-K
BNTX
BioNTech SE
15 Mar 22
Current report (foreign)
6:59pm
6-K
BNTX
BioNTech SE
8 Mar 22
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
8:48am
6-K
BNTX
BioNTech SE
24 Feb 22
Pfizer and BioNTech Receive Positive CHMP Opinion for COVID-19 Vaccine Booster in Adolescents 12 through 17 Years of Age in the European Union
4:39pm
6-K
BNTX
BioNTech SE
22 Feb 22
BioNTech and Medigene Announce Global Collaboration
6:41am
6-K
BNTX
BioNTech SE
16 Feb 22
Current report (foreign)
9:00am
SC 13G/A
BNTX
BioNTech SE
14 Feb 22
BioNTech SE / Medine GmbH ownership change
4:23pm
6-K
BNTX
BioNTech SE
11 Feb 22
Current report (foreign)
4:54pm
SC 13G/A
BNTX
BioNTech SE
11 Feb 22
BioNTech SE / ATHOS KG ownership change
12:00am
6-K
BNTX
BioNTech SE
9 Feb 22
Current report (foreign)
7:53am
6-K
BNTX
BioNTech SE
3 Feb 22
The curious case of the BioNTech priority review voucher
9:21am
6-K
BNTX
BioNTech SE
1 Feb 22
Current report (foreign)
5:06pm